Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 137,617 | 80,486 | 79,634 | 113,839 | 170,098 |
| Receivables | 33,719 | 32,382 | 24,059 | 18,291 | 20,664 |
| Inventories | 7,346 | 7,993 | 9,932 | 10,172 | 14,608 |
| Other current assets | 0 | 0 | 8,819 | 6,642 | 6,618 |
| TOTAL | $187,042 | $128,404 | $122,444 | $148,944 | $211,988 |
| Non-Current Assets | |||||
| PPE Net | 1,812 | 1,942 | 1,970 | 2,146 | 2,330 |
| Intangibles | 40,994 | 41,445 | 42,497 | 43,665 | 44,093 |
| Other Non-Current Assets | 9,458 | 9,819 | 10,379 | 10,785 | 10,230 |
| TOTAL | $52,264 | $53,206 | $54,847 | $56,595 | $56,653 |
| Total Assets | $239,306 | $181,610 | $177,291 | $205,539 | $268,641 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 10,310 | 21,068 | 16,110 | 17,270 | 28,714 |
| Accrued Expenses | 45,974 | 38,170 | N/A | N/A | N/A |
| Other current liabilities | N/A | N/A | 31,221 | 29,213 | 32,925 |
| TOTAL | $61,284 | $59,238 | $47,330 | $46,484 | $61,639 |
| Non-Current Liabilities | |||||
| Long Term Debt | 178,970 | 237,698 | 237,051 | 243,802 | 243,429 |
| Other Non-Current Liabilities | 8,530 | 8,675 | 8,943 | 9,342 | 8,782 |
| TOTAL | $187,500 | $246,373 | $245,994 | $253,144 | $252,211 |
| Total Liabilities | $248,784 | $305,611 | $293,324 | $299,628 | $313,850 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,864 | 7,757 | 5,456 | 5,446 | 5,434 |
| Common Shares | 393 | 300 | 273 | 272 | 272 |
| Retained earnings | -918,328 | -878,945 | -836,858 | -804,247 | -752,270 |
| TOTAL | $-9,478 | $-124,001 | $-116,034 | $-94,089 | $-45,209 |
| Total Liabilities And Equity | $239,306 | $181,610 | $177,291 | $205,539 | $268,641 |